Quaker Houghton (KWR) reported a solid fourth quarter for 2025, with net sales increasing 6% year-over-year to $468.5 million. Growth was primarily driven by strategic acquisitions, including Dipsol, and favorable currency translation, which offset a slight decline in organic volumes. The company saw significant margin improvement, with non-GAAP earnings per diluted share rising 24% to $1.65 and adjusted EBITDA growing 11% to $71.9 million.